Mirror Biologics, Inc. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2019

Location

Wesley Chapel FL US

Primary Industry

Biotechnology

About

Founded in 2019 and based in Florida, US, Mirror Biologics, Inc. operates as a biopharmaceutical company that manufactures immunotherapy products. Michael Har-Noy is the founder and acting CEO of the company as of 2022. In October 2022, Mirror Biologics, Inc. raised USD 20 million in venture funding from Bradbury Asset Management (Hong Kong), Limited Fund. The company also operates in Jerusalem, Israel; Bangkok, Thailand; Kuala Lumpur, and Malaysia. The company provides its lead product, AlloStim®, which is a patented bioengineered, non-genetically altered, ex-vivo differentiated, and expanded CD4+ Th1-like memory cell with anti-CD3/anti-CD28 coated microbeads attached. AlloStim® cells do not directly kill tumors or virally infected cells; instead, they are rejected and removed by the host immune system soon after administration. The firm offers The Mirror Effect® technology platform that addresses unmet medical needs for the treatment and prevention of cancers, infectious diseases, and the medical problems associated with the weakening or senescence of the immune system. Mirror Biologics' manufacturing programs include GMP manufacturing, living immune cell manufacturing, bioreactors, and cloud-controlled pods. The organization plans to use the October 2022 funding to assist in its planned transition from a research and early clinical development stage to a late clinical development and pre-commercial stage biopharmaceutical company, as well as to support the completion of its C-suite and senior management leadership team. In addition, these funds support the expansion of its current clinical development programs in the USA and provide support for the expansion of its GMP manufacturing capacity in Jerusalem, and the establishment of an in-house Clinical Research Center and state-of-the-art R&D and bioengineering labs, including a BSL3 viral research lab in Tampa.

Current Investors

Bradbury Asset Management

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Biopharmaceuticals, Healthcare

Website

www.mirrorbio.com

Verticals

Manufacturing

Company Stage

Early Stage

Total Amount Raised

Subscriber access only

Employee Data

Want to see the Employee Count?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.